Adaptive immunity to SARS-CoV-2 and COVID-19
Increasing Calls for Brain Health Action at High-level New York Event
September 30, 2026
At the Global Brain Coalition’s Brain Days, which took place alongside the 81st United Nations General Assembly (UNGA81) during High-level Week, policymakers, scientists, clinicians, patient advocates and international organisations gathered to discuss how brain health can move higher up the global policy agenda.
First EAN Annual Report Reviews Major Milestones of 2025
August 7, 2026
Latest Posts
-
-
Breaking newsEAN NewsCOVID-19Research
MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells
January 28, 2021MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells -
Breaking newsEAN NewsCOVID-19Research
Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19
January 28, 2021Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19 -
Breaking newsEAN NewsCOVID-19Research
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
January 28, 2021SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population -
Breaking newsEAN NewsCOVID-19Research
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge
January 28, 2021Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge -
Breaking newsEAN NewsCOVID-19Research
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
January 28, 2021Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study -
Breaking newsEAN NewsCOVID-19Research
Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools
January 28, 2021Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools -
Breaking newsEAN NewsCOVID-19Research
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
January 28, 20216-month consequences of COVID-19 in patients discharged from hospital: a cohort study -
Breaking newsEAN NewsCOVID-19Research
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
January 28, 2021Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data -
Breaking newsEAN NewsCOVID-19Research
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2 A Systematic Review and Meta-analysis
January 28, 2021Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2 A Systematic Review and Meta-analysis -
Breaking newsEAN NewsCOVID-19Research
Open Schools, COVID-19, and Child and Teacher Morbidity in Sweden
January 28, 2021Open Schools, COVID-19, and Child and Teacher Morbidity in Sweden -
Breaking newsEAN NewsCOVID-19Research
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
January 28, 2021Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination -
Breaking newsEAN NewsCOVID-19Research
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S COVID-19 Vaccine
January 28, 2021Interim Results of a Phase 1–2a Trial of Ad26.COV2.S COVID-19 Vaccine -
Breaking newsEAN NewsCOVID-19Research
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
January 28, 2021Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine -
Breaking newsEAN NewsCOVID-19Research
Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults
January 28, 2021Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults









